UK's 'Innovation Pass' Pilot Starts, But With Only One Year Of Funding
This article was originally published in The Pink Sheet Daily
The UK's Innovation Pass Scheme may alleviate "NICE blight" for a small number of drugs for rare diseases, but its long-term future is uncertain.
You may also be interested in...
UK's New Cancer Drug Fund Might Not Alleviate Regional Access Disparities
The United Kingdom is creating a £600 million Cancer Drugs Fund to improve treatment access but a consultation document on the initiative is doing little to ease concerns about regional disparities in care.
Pipeline Watch: Phase III Readouts in Wilson Disease, Parkinson's Disease And COVID-19
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.